Study reveals impact of adverse childhood experiences on teen mental health

As the spot­light trains on ac­cess to biosim­i­lars, No­var­tis’ gener­ics unit on Thurs­day re­leased a glob­al ac­tion plan to boost biosim­i­lar adop­tion by 2030. The

Bio­gen’s lead­ers de­fend­ed their Ei­sai-part­nered Leqem­bi dur­ing a first-quar­ter earn­ings up­date on Wednes­day, say­ing the Alzheimer’s treat­ment is on a path to greater up­take as